ABOUT CELYAD ONCOLOGY
Celyad Oncology is a biotechnology company focused primarily on unlocking the potential of its intellectual property.
Latest News
Our strategy
Our differentiated strategy includes the development of technology platforms and CAR T-cell candidates to broaden the range of cancer indications and tackle the main limitations of current CAR T-cell therapies
Stay informed about the latest news!
Sign up FOR our newsletter
By clicking on “send”, you consent that your personal data will be processed by us in order to send you our newsletter. You have the right to access, rectify, erase your data, to restrict the processing and the right to withdraw your consent at any time. You can find more information on how we process your data in our Privacy Policy.
